ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke

ClinicalTrials.gov ID: NCT05953480

Public ClinicalTrials.gov record NCT05953480. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 9:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Multinational, Randomized, Double-blind Study to Investigate the Efficacy and Safety of Redasemtide (S-005151) Compared With Placebo in Adult Participants With Acute Ischemic Stroke

Study identification

NCT ID
NCT05953480
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Shionogi
Industry
Enrollment
680 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Redasemtide Biological

Drug · Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 13, 2023
Primary completion
Jun 29, 2026
Completion
Jun 29, 2026
Last update posted
May 5, 2026

2023 – 2026

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
Banner University of Arizona Medical Center Tucson Arizona 85724
Intercoastal Medical Group Sarasota Florida 34239-3228
Augusta University Augusta Georgia 30912-0004
Mercyhealth Javon Bea Hospital- Riverside Rockford Illinois 61114-2300
Community Hospital Munster Indiana 46321-2901
Sinai Hospital of Baltimore Baltimore Maryland 21215-5216
Munson Healthcare Traverse City Michigan 49684
Mayo Clinic Hospital-Rochester, St. Mary's Campus - PPDS Rochester Minnesota 55905-0001
North Shore University Hospital-300 Community Dr Manhasset New York 11030-3816
Nuvance Health Medical Practice, PC- Neurosurgery Poughkeepsie New York 12601-3986
Summa Health System - Akron Campus Akron Ohio 44304
Ohio State University Wexner Medical Center Columbus Ohio 43210-1240
Ascension St. John Clinical Research Institute Tulsa Oklahoma 74104-5437
Baylor University Medical Center - 3500 Gaston Ave Dallas Texas 75246
Houston Methodist Hospital Houston Texas 77030-2726
Baylor Scott & White - Plano Brain & Spine Center Plano Texas 75093-5338
University Health-University Hospital San Antonio Texas 78229-3931

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 133 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05953480, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2026 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05953480 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →